Zhenran Wang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
-
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Circular RNAs in diseases
- Histone Deacetylase Inhibitors Research
- Ubiquitin and proteasome pathways
Papers in
-
- Epigenetics and DNA Methylation 8
- RNA modifications and cancer 5
- Cancer-related gene regulation 4
- Ubiquitin and proteasome pathways 3
-
- MicroRNA in disease regulation 4
- Cancer-related molecular mechanisms research 4
- Co-authors
- Songqing He (9 shared papers)Guangying Qi (10 shared papers)Shengguang Yuan (9 shared papers)Bo Tang (10 shared papers)Shuiping Yu (7 shared papers)Xingsi Liang (7 shared papers)Fang Tang (6 shared papers)Bo Tang (2 shared papers)
- Journals
- Journal of Experimental & Clinical Cancer Research (3 papers)Biomedical Reports (2 papers)Oncotarget (2 papers)Scientific Reports (1 paper)Current Topics in Medicinal Chemistry (1 paper)
- Partner nations
- ChinaJapanUnited States
In The Last Decade
Zhenran Wang
22 papers receiving 742 citations
Peers
Comparison fields: 5 of 91
- Cancer Research 268
- Molecular Biology 539
- Toxicology 19
- Oncology 136
- Immunology 60
Countries citing papers authored by Zhenran Wang
This map shows the geographic impact of Zhenran Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhenran Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhenran Wang more than expected).
Fields of papers citing papers by Zhenran Wang
This network shows the impact of papers produced by Zhenran Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhenran Wang. The network helps show where Zhenran Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhenran Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 89 | |
| 2 | 2016 | 71 | |
| 3 | 2015 | 60 | |
| 4 | 2015 | 59 | |
| 5 | KDM5B is overexpressed in gastric cancer and is required for gastric cancer cell proliferation and metastasis. | 2015 | 57 |
| 6 | 2016 | 50 | |
| 7 | 2022 | 48 | |
| 8 | 2012 | 48 | |
| 9 | 2016 | 48 | |
| 10 | 2015 | 45 | |
| 11 | 2012 | 28 | |
| 12 | 2014 | 28 | |
| 13 | 2015 | 25 | |
| 14 | 2023 | 22 | |
| 15 | 2018 | 21 | |
| 16 | 2014 | 19 | |
| 17 | 2021 | 12 | |
| 18 | 2015 | 9 | |
| 19 | 2013 | 7 | |
| 20 | 2024 | 1 |
About Zhenran Wang
Zhenran Wang is a scholar working on Molecular Biology, Cancer Research, Oncology, Immunology and Surgery, having authored 23 papers that have together received 749 indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (8 papers), RNA modifications and cancer (5 papers), MicroRNA in disease regulation (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer-related gene regulation (4 papers), Ubiquitin and proteasome pathways (3 papers), Immune cells in cancer (3 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (268 citations), Molecular Biology (539 citations), Toxicology (19 citations), Oncology (136 citations) and Immunology (60 citations). Zhenran Wang has collaborated with scholars based in China, Japan and United States. Frequent co-authors include Songqing He, Guangying Qi, Shengguang Yuan, Bo Tang, Shuiping Yu, Xingsi Liang, Fang Tang, Bo Tang, Yangchao Wei and Guangyu Zhang. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Biomedical Reports, Oncotarget, Scientific Reports and Current Topics in Medicinal Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.